Lies&damnedlies, rather than a dividend cap valuation, another way of looking at it:
If they grow overheads to $35m and are generating $180m revenue
= $145m gross profit at 90% margin, so $130m profit before tax and ~$100m NPAT.
What P/E ratio would be appropriate for a high growth high margin med device company?
How long is a piece of string but the answer would start with at least a 2 in front of it.
My guess is if they hit $180m its at least a $2b mkt cap company, which is about $1/sh..
IPD chart, page-656
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
-0.002(2.21%) |
Mkt cap ! $137.5M | |||
| Open | High | Low | Value | Volume |
| 6.7¢ | 6.7¢ | 6.7¢ | $2.651K | 39.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 406741 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.7¢ | 24380 | 1 |
View Market Depth
| Last trade - 10.32am 10/07/2024 (20 minute delay) ? |
| IPD (ASX) Chart |